Biosergen AS (BIOSGN) — Cash Flow Reinvestment Rate
Latest as of June 2024:
0.33x
Biosergen AS (BIOSGN) has a Cash Flow Reinvestment Rate of 0.33x as of June 2024, reinvesting Skr4.41 Million (capex Skr0.00 plus investments Skr-4.41 Million) from operating cash flow of Skr13.45 Million. See BIOSGN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.33x
(Capex + Investments) / Operating CF
Total Reinvested
Skr4.41 Million
Capex + Investments
Operating Cash Flow
Skr13.45 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Biosergen AS (None–None)
Year-by-year capital reinvestment analysis for Biosergen AS. See how financially flexible is Biosergen AS to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow